Penta ID Innovation and Cromsource have entered a partnership focused on improving drug development for pediatric patients. The collaboration combines Penta’s expertise in pediatric infectious diseases and Cromsource’s capabilities in managing worldwide drug development programs to address the challenges of bringing new therapies to children.      “We are thrilled to partner with such a prestigious and dynamic organization,” said Oriana Zerbini, chief executive officer, C...